Henry Ji, Ph.D.

Chairman, President, & CEO
Sorrento Therapeutics

Henry Ji, Ph.D. Chairman, President and CEO , Sorrento Therapeutics

  • 25+ years of experience in the biotechnology and life sciences industry
  • Dr. Ji co-founded Sorrento and has served as a director since 2006, CEO and President since 2012, and Chairman since 2017
  • During his tenure at Sorrento, he has engineered and led a phenomenal growth of Sorrento through acquisition and merger including Bioserv, Scilex Pharmaceuticals, Concortis Biotherapeutics, Levena Biopharma, LACEL, TNK Therapeutics, Virttu Biologics, Ark Animal Health, and Sofusa Lymphatic Delivery Systems
  • Served as Sorrento’s Chief Scientific Officer from 2008 to 2012 and as its Interim CEO from 2011 to 2012
  • Prior to Sorrento, he held senior executive positions at CombiMatrix, Strategen and also co-founded Stratagene Genomics, a subsidiary of Stratagene, and served as its President & CEO and Director of the Board
  • B.S. and Ph.D.